Literature DB >> 21635136

Assessment of dyspnea in asthma: validation of The Dyspnea-12.

Janelle Yorke1, Anne-Marie Russell, Jeff Swigris, Caroline Shuldham, Carol Haigh, Nikki Rochnia, Jennifer Hoyle, Paul W Jones.   

Abstract

BACKGROUND: Dyspnea is a prominent symptom in asthma. The Dyspnea-12 (D-12), an instrument that quantifies breathlessness using 12 descriptors that tap the physical and affective aspects, has shown promise for the measurement of dyspnea in cardiorespiratory disease.
OBJECTIVE: We report the results of a study designed to test the validity and reliability of the D-12 in a population of patients with asthma.
METHODS: This cross-sectional study included 102 patients with asthma. Subjects completed the D-12, Hospital Anxiety and Depression scale, St. George's Respiratory Questionnaire (SGRQ), and Medical Research Council scale. Confirmatory factor analysis confirmed the two-component structure of the D-12 (i.e., seven items that tap the physical aspects of breathlessness and five items that tap the affective aspects).
RESULTS: The D-12 subscales had excellent internal reliability (Cronbach's alpha for the "physical" score was 0.94 and the affective score was 0.95). The D-12 physical component was more strongly correlated with SGRQ Symptoms (r = 0.648), SGRQ Activities (r = 0.635) and Medical Research Council grade (r = 0.636), while the affective component was more strongly correlated with SGRQ Impacts (r = 0.765) and Hospital Anxiety and Depression scale scores (anxiety r = 0.641 and depression r = 0.602).
CONCLUSION: This study supports validity of the D-12 for use in the assessment of dyspnea of patients with asthma. It assesses one of the most pertinent symptoms of asthma from two viewpoints-physical and affective.

Entities:  

Mesh:

Year:  2011        PMID: 21635136      PMCID: PMC3149863          DOI: 10.3109/02770903.2011.585412

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  26 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Sensory and affective aspects of dyspnea contribute differentially to the Borg scale's measurement of dyspnea.

Authors:  Andreas von Leupoldt; Rita Ambruzsova; Simone Nordmeyer; Nina Jeske; Bernhard Dahme
Journal:  Respiration       Date:  2006       Impact factor: 3.580

3.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.

Authors:  P W Jones; F H Quirk; C M Baveystock; P Littlejohns
Journal:  Am Rev Respir Dis       Date:  1992-06

4.  The impact of emotions on the sensory and affective dimension of perceived dyspnea.

Authors:  Andreas von Leupoldt; Corinna Mertz; Sarah Kegat; Swantje Burmester; Bernhard Dahme
Journal:  Psychophysiology       Date:  2006-07       Impact factor: 4.016

5.  Distinguishable types of dyspnea in patients with shortness of breath.

Authors:  P M Simon; R M Schwartzstein; J W Weiss; V Fencl; M Teghtsoonian; S E Weinberger
Journal:  Am Rev Respir Dis       Date:  1990-11

6.  Asthma symptoms: influence of personality versus clinical status.

Authors:  C Put; M Demedts; O Van Den Bergh; K Demyttenaere; G Verleden
Journal:  Eur Respir J       Date:  1999-04       Impact factor: 16.671

7.  Negative affectivity and the influence of suggestion on asthma symptoms.

Authors:  Claudia Put; Omer Van den Bergh; Elke Van Ongeval; Steven De Peuter; Maurits Demedts; Geert Verleden
Journal:  J Psychosom Res       Date:  2004-09       Impact factor: 3.006

8.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Authors:  J C Bestall; E A Paul; R Garrod; R Garnham; P W Jones; J A Wedzicha
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

9.  Descriptors of breathlessness in cardiorespiratory diseases.

Authors:  D A Mahler; A Harver; T Lentine; J A Scott; K Beck; R M Schwartzstein
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

10.  Dyspnoea at rest and at the end of different exercises in patients with near-fatal asthma.

Authors:  E Barreiro; J Gea; C Sanjuás; R Marcos; J Broquetas; J Milic-Emili
Journal:  Eur Respir J       Date:  2004-08       Impact factor: 16.671

View more
  16 in total

1.  Reliability and validity of the multidimensional dyspnea profile.

Authors:  Paula M Meek; Robert Banzett; Mark B Parsall; Richard H Gracely; Richard M Schwartzstein; Robert Lansing
Journal:  Chest       Date:  2012-01-19       Impact factor: 9.410

Review 2.  Cognitive behavioural therapy (CBT) for adults and adolescents with asthma.

Authors:  Kayleigh M Kew; Marina Nashed; Valdeep Dulay; Janelle Yorke
Journal:  Cochrane Database Syst Rev       Date:  2016-09-21

3.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

4.  Measuring dyspnoea: new multidimensional instruments to match our 21st century understanding.

Authors:  Robert B Banzett; Shakeeb H Moosavi
Journal:  Eur Respir J       Date:  2017-03-02       Impact factor: 16.671

5.  Scalable modEls of Community rehAbilitation for Individuals Recovering From COVID:19 reLated illnEss: A Longitudinal Service Evaluation Protocol-"SeaCole Cohort Evaluation".

Authors:  Benjamin Kelly; Aidan Innes; Marc Holl; Laura Mould; Susan Powell; Danielle Burns; Patrick Doherty; Greg Whyte; James King; Davina Deniszczyc
Journal:  Front Public Health       Date:  2021-05-13

6.  Test-retest reliability of multidimensional dyspnea profile recall ratings in the emergency department: a prospective, longitudinal study.

Authors:  Mark B Parshall; Paula M Meek; David Sklar; Joe Alcock; Paula Bittner
Journal:  BMC Emerg Med       Date:  2012-05-24

Review 7.  Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research.

Authors:  Robert B Banzett; Carl R O'Donnell; Tegan E Guilfoyle; Mark B Parshall; Richard M Schwartzstein; Paula M Meek; Richard H Gracely; Robert W Lansing
Journal:  Eur Respir J       Date:  2015-03-18       Impact factor: 16.671

Review 8.  Sedation in non-invasive ventilation: do we know what to do (and why)?

Authors:  Dan Longrois; Giorgio Conti; Jean Mantz; Andreas Faltlhauser; Riku Aantaa; Peter Tonner
Journal:  Multidiscip Respir Med       Date:  2014-11-04

9.  Reliability and validity of an arabic version of the dyspnea-12 questionnaire for Saudi nationals with chronic obstructive pulmonary disease.

Authors:  Mohammed M Alyami; Sue C Jenkins; Hani Lababidi; Kylie Hill
Journal:  Ann Thorac Med       Date:  2015 Apr-Jun       Impact factor: 2.219

Review 10.  Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.

Authors:  Paul Jones; Marc Miravitlles; Thys van der Molen; Karoly Kulich
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.